Monash IVF Chief Resigns

Monash IVF CEO Resigns Amid Second Embryo Mix-Up: Calls for National Regulation Intensify

This week Monash IVF admitted to a second error in an embryo implant. Photograph: Science Photo Library/ZEPHYR/Getty Images

Another Embryo Error: Monash IVF CEO Steps Down

Monash IVF’s CEO, Michael Knaap, has resigned after the company admitted to a second embryo transfer error within months. The latest incident occurred at the Clayton clinic in Victoria, where a patient’s own embryo was mistakenly transferred instead of her partner’s. This follows a previous error in Brisbane, where a woman gave birth to a child that was not genetically hers due to an embryo mix-up.

The company’s Chief Financial Officer, Malik Jainudeen, will serve as acting CEO.

Financial Impact

The company’s shares have suffered significantly, dropping by over 25% following the latest announcement. Investor confidence has been shaken, with nearly 70 million shares sold off.

Regulatory Response

These incidents have prompted calls for national regulation of the IVF sector, which is currently governed by individual state and territory laws. The Fertility Society of Australia and New Zealand (FSANZ) has advocated for a consistent regulatory framework and the establishment of an independent statutory authority to improve oversight.

Summary Table

Incident DateLocationDescriptionOutcome
April 2025BrisbaneWrong embryo transferred; woman gave birth to another couple’s childPublic apology; internal review
June 2025Clayton, VICPatient’s own embryo transferred instead of partner’sCEO resignation; regulatory investigations
Scroll to Top